Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Merck image

News about Merck

Stay current with all the latest and breaking news about Merck, compare headlines and perspectives between news sources on stories happening today. In total, 168stories have been published about Merck which Ground News has aggregated in the past 3 months.

Covered Most By

pharmaceutical-technology.com

Suggest a source

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Merck News

FDA Approves Merck’s Enflonsia to Prevent RSV in Infants

Merck · United States

FDA Approves Merck’s Enflonsia to Prevent RSV in Infants

51% Center coverage: 37 sources

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial virus, or RSV, a common but potentially serious seasonal illness.The drug, Enflonsia, is a long-acting monoclonal antibody intended to prevent RSV-related lower respiratory tract disease in newborns and infants entering their first RSV season.RSV is a leading cause of hospitalization among infants in the United States, espec…See the Story

Bristol Myers Squibb signs $11bn cancer drug deal with BioNTech

Bristol Myers Squibb signs $11bn cancer drug deal with BioNTech

66% Center coverage: 18 sources

US-German partnership hopes BNT327 will compete with Merck’s bestseller Keytruda See the Story

Revolutionary Single-Dose Cholesterol Treatment Could Reduce Levels by up to 69%

Revolutionary Single-Dose Cholesterol Treatment Could Reduce Levels by up to 69%

Coverage: 5 sources

If confirmed, this could be useful for billilons of people.See the Story

Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery - Merck & Co (NYSE:MRK)

100% Center coverage: 3 sources

The U.S. Food and Drug Administration (FDA) on Friday approved Merck & Co Inc.’s (NYSE:MRK) Keytruda (pembrolizumab) for adult patients with resectable locally advanced head and neck squamous cell carcinoma (HNSCC) whose tumors express PD-L1 (combined positive score of at least 1), as a single agent as neoadjuvant treatment, continued as adjuvant treatment in combination with radiotherapy (RT) with or without cisplatin and then as a single agent…Cancer · United States See the Story

How You Can Help Protect Your Baby Against Rotavirus

67% Center coverage: 3 sources

(BPT) - If you are a parent, you may have heard about rotavirus — an easily spread disease that can pose a serious risk to infants and young children. Symptoms can include mild to severe diarrhea, vomiting and fever. In ...Hospitals · United States See the Story

Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Industry Developments

Merck has reportedly made an acquisition offer exceedin […] The post Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Industry Developments first appeared on GeneOnline News. The post Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Industry Developments appeared first on GeneOnline News.Merck Read Article

Rein Therapeutics study on clinical hold; Beam updates sickle cell therapy data

Plus, news about Enliven Therapeutics, Merck's Keytruda and Celldex: FDA places hold on Rein study: The agency has “non-clinical requests” for Rein Therapeutics’ Phase 2 trial in idiopathic pulmonary fibrosis, per a Thursday ...Merck Read Article

Demystifying the AI Chip Supply Chain - Here's How NVIDIA & Others Rely On A Complex Web Of Companies To Make Their Chips

The widespread boom in the use of AI chips benefits many companies that often do not come into the limelight. Most observers often credit GPU designer NVIDIA Corporation as being responsible for leading the AI charge, but the reality is that there is a complex web of companies stretching from Asia to the US that play important roles throughout this supply chain. With the UN estimating that the AI market is expected to touch $4.8 trillion by 2033…Artificial Intelligence · South Korea Read Article

FDA Restricts Use of Immunotherapies in Gastric, Esophageal Cancers

100% Center coverage: 1 sources

(MedPage Today) -- The FDA narrowed the indications for pembrolizumab (Keytruda) and nivolumab (Opdivo) in gastric, gastroesophageal junction (GEJ), and esophageal cancers, according to letters sent to the respective drugmakers. The agency had...Merck · United States See the Story

Merck's Potential Blockbuster Cholesterol Pill Succeeds in Late-stage Studies

Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers beyond its cancer drugs... Reuters Health InformationMerck Read Article

Price Over Earnings Overview: Merck & Co - Merck & Co (NYSE:MRK)

100% Center coverage: 1 sources

Speaking on the company’s first-quarter earnings call in April, Merck & Co. [NYSE: MRK] chairman and CEO Robert M. Davis sought to reassure analysts that the company was very much interested in growing through mergers and acquisitions (M&A) despite an uncertain economic climate that has dampened dealmaking among biopharmas. “I am confident that you are going to see us get some stuff done as we move forward because we’ve got things in the queue t…Merck · Maryland See the Story

Breaking News Topics Related to Merck